Family Medicine Perspective

 
 
  • Beware of Biased AI   AI to "aid" physician diagnosis may not be as helpful as we expect it to be.
  • Infographic: How Nurses Would Choose With a Career Do-Over In a survey, around 7 in 10 nurses said they would choose nursing again at the start of a career. But among those with regrets, only 4 in 10 would stay in nursing even if they worked fewer hours.
  • Should BP Guidelines Be Sex-Specific?   New data show that the risk for CVD death among women increases at lower systolic blood pressures than it does among men.
  • Primary Care, Meet Lifestyle Medicine   Dr Kenny Lin speaks with Dr Alka Gupta about implementing lifestyle medicine into primary care practice, including billable shared medical appointments to help patients navigate lifestyle changes.
  • Dec 15 2023 This Week in Cardiology   FDA approves PFA, breakthrough in PAH, residual leaks after percutaneous LAAO, OAC in low-intermediate risk people are the topics John Mandrola, MD, discusses in this week’s podcast.
  • Parkinson's Disease Highlights 2023   Neurologists Kathrin LaFaver and Alberto Espay review the top Parkinson's disease research in 2023, including biomarkers and what the data on GLP-1 receptor agonists may mean for future research.
  • The Top Cardiology Trials of 2023   For this year's review, Bob Harrington and Mike Gibson revisit the major cardiology conferences -- from ACC in New Orleans to AHA in Philly.
  • ASH 2023: Key Insights on Advances in DLBCL   Dr Suchitra Sundaram highlights some of the practice-changing data presented at ASH 2023.
  • Cysteamine and Melasma Cysteamine is a natural agent that has recently garnered attention primarily for one indication: melasma.
  • Infographic: Female Physicians Close Their Wealth Gap Female physicians' survey answers about their net worth show a gender gap vs male doctors (although it's narrowing) and reveal their saving and borrowing habits.
  • Erectile Dysfunction Rx: Give It a Shot   Dr Rachel Rubin shares her erectile dysfunction toolbox, revealing the wide array of treatments available for this common problem.
  • Quitting Medical School Why would a physician who was burdened with student loans enter a subspecialty that would limit his or her ability to pay it off?
  • All In: Two Cancers, One Surgical Team Who's Not Giving Up   Surgeons know not to count on miracles, but sometimes they can happen. Our cameras follow a surgical team as they work together to treat a patient with an uncertain outcome.
  • SABCS 2023: Highlights in HR+/HER2- Breast Cancer   Tarah J. Ballinger, MD, provides her biggest takeaways from SABCS 2023 in HR+/HER2- breast cancer.
  • Advancing Cardiovascular Health Equity Through Prevention Science This review highlights achieving optimal cardiovascular health via a coordinated multidisciplinary approach. Conscious efforts to improve community engagement and health care policy are needed to mitigate inequities and achieve social justice.
  • How to Prescribe Zepbound Recently approved tirzepatide joins semaglutide as an option for patients with obesity. Beverly Tchang, MD, offers her recommendations based on her experience for prescribing.
  • Medscape Nurse Career Satisfaction Report 2023 Several categories of nurses describe what makes them happiest and unhappiest with their career, how the abuse they experience shapes their views, and other facets of career satisfaction.
  • In General, I'm Happy I'm a general neurologist. I consider myself a jack of all (or at least most) trades in my field and a master of none.
  • Why Are Prion Diseases on the Rise?   Remember the outbreak of "mad cow disease" in the 1990s? Creutzfeldt-Jakob is increasing again, but this time, we don't know why.
  • Why I Don't Worry About Nephrotoxicity With Zosyn   Dr Paul Auwaerter explains why a warning about nephrotoxicity doesn't influence his decision to use Zosyn when it's indicated.